Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|May 11, 2016
Advances of Phenoxazines: Synthesis, Reactivity and Their Medicinal ApplicationsSotirios Katsamakas, Alexandros L Zografos, Vasiliki Sarli
Current Medicinal Chemistry|February 28, 2015
Considering autotaxin inhibitors in terms of 2D-QSAR and 3D-mapping- review and evaluationSotirios Katsamakas, Eleftherios Bermperoglou, Dimitra Hadjipavlou-Litina
Molecules (Basel, Switzerland)|September 13, 2016
Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug DesignSotirios Katsamakas, Anastasios G Papadopoulos, Dimitra Hadjipavlou-Litina
Future Medicinal Chemistry|April 11, 2017
RGD-mediated delivery of small-molecule drugsSotirios Katsamakas, Theodora Chatzisideri, Savvas Thysiadis, et al.
European Journal of Medicinal Chemistry|December 3, 2015
Synthesis and evaluation of gallocyanine dyes as potential agents for the treatment of Alzheimer's disease and related neurodegenerative tauopathiesSpyros Mpousis, Savvas Thysiadis, Nicolaos Avramidis, et al.
Future Medicinal Chemistry|November 8, 2017
Novel c(RGDyK)-based conjugates of POPAM and 5-fluorouracil for integrin-targeted cancer therapySavvas Thysiadis, Sotirios Katsamakas, Panagiotis Dalezis, et al.
Bioorganic Chemistry|July 4, 2018
Design and synthesis of gallocyanine inhibitors of DKK1/LRP6 interactions for treatment of Alzheimer's diseaseSavvas Thysiadis, Sotirios Katsamakas, Spyros Mpousis, et al.
Chemical Biology & Drug Design|April 23, 2017
Targeting on poly(ADP-ribose) polymerase activity with DNA-damaging hybrid lactam-steroid alkylators in wild-type and BRCA1-mutated ovarian cancer cellsDimitrios T Trafalis, Aikaterini Polonifi, Panayiotis Dalezis, et al.
Future Medicinal Chemistry|September 21, 2019
Examining barbiturate scaffold for the synthesis of new agents with biological interestSotirios Katsamakas, Anastasios G Papadopoulos, Maria G Kouskoura, et al.
Bioorganic & Medicinal Chemistry|January 29, 2016
Discovery of novel phenoxazinone derivatives as DKK1/LRP6 interaction inhibitors: Synthesis, biological evaluation and structure-activity relationshipsSavvas Thysiadis, Spyros Mpousis, Nicolaos Avramidis, et al.
Pageof 2